Federal lawmakers expressed surprise at the lack of regulatory oversight over medical uses of radiation at hearings in the U.S. Congress today. While everyone in attendance agreed that the current regulatory environment needs fixing, the thorny question is how to go about doing it.
Congress surprised at lack of medical radiation oversight
Feb 25, 2010
Latest in Radiation Oncology/Therapy
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
